Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Biomerica (BMRA) Income from Continuing Operations (2016 - 2026)

Biomerica's Income from Continuing Operations history spans 17 years, with the latest figure at 1312000.0 for Q1 2026.

  • On a quarterly basis, Income from Continuing Operations fell 12.81% to 1312000.0 in Q1 2026 year-over-year; TTM through Feb 2026 was 4174000.0, a 12.42% increase, with the full-year FY2025 number at 4973000.0, up 15.63% from a year prior.
  • Income from Continuing Operations hit 1312000.0 in Q1 2026 for Biomerica, up from 1320000.0 in the prior quarter.
  • Over the last five years, Income from Continuing Operations for BMRA hit a ceiling of 2000.0 in Q3 2025 and a floor of 2072000.0 in Q3 2022.
  • Historically, Income from Continuing Operations has averaged 1323537.94 across 5 years, with a median of 1337000.0 in 2024.
  • Biggest five-year swings in Income from Continuing Operations: tumbled 1483.98% in 2023 and later soared 100.15% in 2025.
  • Tracing BMRA's Income from Continuing Operations over 5 years: stood at 1626000.0 in 2022, then increased by 7.32% to 1507000.0 in 2023, then soared by 36.96% to 950000.0 in 2024, then plummeted by 38.95% to 1320000.0 in 2025, then grew by 0.61% to 1312000.0 in 2026.
  • Business Quant data shows Income from Continuing Operations for BMRA at 1312000.0 in Q1 2026, 1320000.0 in Q4 2025, and 2000.0 in Q3 2025.